WindRose Health Investors Backs Third Wave Recovery Systems; TWRx Acquires SRX
September 14, 2022
WindRose Health Investors completed a growth equity investment in Third Wave Recovery Systems (TWRx) to support the company's expansion in pharmaceutical rebate administration for hospitals, long-term care facilities, and specialty providers. In conjunction with the investment, TWRx acquired SRX, LLC — a rebate management specialist for skilled nursing and long-term care — and appointed a new executive team to lead the combined business.
- Buyers
- WindRose Health Investors, LLC, Third Wave Recovery Systems, LLC
- Targets
- Third Wave Recovery Systems, LLC, SRX, LLC
- Platforms
- Third Wave Recovery Systems, LLC
- Industry
- Healthcare Services
- Location
- Florida, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
WindRose Health Investors and Francisco Partners Invest in Avalon Healthcare Solutions
January 12, 2026
Healthcare Services
WindRose Health Investors has completed a growth investment in Avalon Healthcare Solutions, a Tampa-based diagnostic intelligence and lab benefits management platform. Existing investor Francisco Partners also made an additional investment to support Avalon’s continued product development and scaling for health plan clients.
-
WindRose Health Investors Invests in Stellus Rx
December 8, 2025
Healthcare Services
WindRose Health Investors has made a strategic growth investment in Stellus Rx, a Plano, Texas–based technology-enabled, value-based pharmacy care management platform. The undisclosed transaction will fund Stellus Rx’s expansion of clinical and operational capabilities and the scaling of its platform to serve additional patient populations nationwide.
-
WindRose Health Investors Recapitalizes RevHealth
July 27, 2022
Healthcare Services
WindRose Health Investors completed a recapitalization of RevHealth, a Morristown, New Jersey-based omnichannel healthcare communications agency. The investment will provide capital to support RevHealth's growth and expansion of services; founders Bruce Epstein, Bruce Medd, and Brian Wheeler will continue to lead the company and remain significant shareholders.
-
WindRose Health Investors Recapitalizes Terrapin Pharmacy
January 5, 2022
Healthcare Services
WindRose Health Investors completed a recapitalization of Terrapin Pharmacy LLC, a closed-door specialty pharmacy serving behavioral health and long-term care populations in the Mid-Atlantic. The investment provides growth capital to support geographic expansion and increased market share; terms were not disclosed.
-
WindRose Health Investors Recapitalizes Lykan Bioscience Holdings
June 4, 2019
Biotechnology
WindRose Health Investors completed an equity recapitalization of Lykan Bioscience Holdings, LLC, a Hopkinton, Massachusetts-based contract manufacturing services organization focused on cell and gene therapy production and logistics. The investment provides capital to support growth and the build-out of a 60,000+ square foot cGMP facility to expand manufacturing capacity; terms were not disclosed.
-
WindRose Health Investors Recapitalizes Traditions Behavioral Health
November 14, 2018
Healthcare Services
Funds managed by WindRose Health Investors completed a recapitalization of Traditions Behavioral Health (TBH), a West Coast provider of permanent outsourced physician psychiatric services. WindRose partnered with TBH's executive team (founder and CEO Gary A. Hayes remains in place) to provide growth capital to expand into new U.S. markets, broaden services and increase its network of psychiatrists.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.